Chemoinformaics analysis of 5,7-Dihydroxy-2-(hydroxymethyl)-4H-1-benzopyran-4-one
| Molecular Weight | 208.169 | nRot | 1 |
| Heavy Atom Molecular Weight | 200.105 | nRig | 12 |
| Exact Molecular Weight | 208.037 | nRing | 2 |
| Solubility: LogS | -2.715 | nHRing | 1 |
| Solubility: LogP | 0.395 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 11 |
| nHA | 5 | APOL | 26.0443 |
| nHD | 3 | BPOL | 10.6297 |
| QED | 0.641 |
| Synth | 2.516 |
| Natural Product Likeliness | 1.881 |
| NR-PPAR-gamma | 0.38 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.931 |
| HIA | 0.107 |
| CACO-2 | -4.87 |
| MDCK | 0.00000776 |
| BBB | 0.013 |
| PPB | 0.667271 |
| VDSS | 0.817 |
| FU | 0.453834 |
| CYP1A2-inh | 0.929 |
| CYP1A2-sub | 0.414 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.073 |
| CYP2c9-sub | 0.854 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.434 |
| CYP3a4-inh | 0.113 |
| CYP3a4-sub | 0.111 |
| CL | 9.509 |
| T12 | 0.915 |
| hERG | 0.032 |
| Ames | 0.5 |
| ROA | 0.029 |
| SkinSen | 0.868 |
| Carcinogencity | 0.036 |
| EI | 0.914 |
| Respiratory | 0.287 |
| NR-Aromatase | 0.264 |
| Antiviral | No |
| Prediction | 0.811635 |